🇮🇳 India Stock Screener ← Switch market ★ Elite Club ⚡ StockGenie AI

TTK Healthcare Limited TTKHLTCARE NSEPHARMA

Healthcare · Drug Manufacturers - General · India
https://www.ttkhealthcare.com

TTK Healthcare Limited engages in the animal welfare, consumer product, medical device, protective device, food, and other businesses in India. It operates through Animal Welfare, Consumer Products, Medical Devices, Protective Devices, Foods, and Others segments. The Animal Welfare segment offers various feed supplements, liver correctives, fertility inducers, antibiotics, antiparasiticides, antispasmodics, cervical dilators, cocktail enzymes, etc. to veterinarians, dairy, poultry and aqua farmers, and pet parents. The Consumer Products segment is involved in the marketing and distribution of baby care products under the Woodward's Gripe water name; personal care products and cosmetics under the EVA name; home care products, such as scrubbers under the Good Home name; and air fresheners. The Medical Devices segment manufactures and markets artificial heart valves under the TTK Chitra name, as well as orthopedic implants and instruments for knee and hip replacements. The Protective Devices segment manufactures and markets sexual wellness products, including male contraceptives under the Skore brand name, and other allied products. The Foods segment engages in the manufacturing and marketing of food products, including papads under the Fryums name; and cereal, potato, rice, pulses, and corn-based products. The Others segment prints and publishes maps, atlases, guidebooks, and educational publications under the TTK brand name. The company was founded in 1928 and is headquartered in Chennai, India. TTK Healthcare Limited operates as a subsidiary of TT Krishnamachari & Co., Ltd.

READ MORE ›
₹891.85
-25.92% 1Y

Market & Price

Market Cap
₹1,260.21 Cr
Current Price
₹891.85
High / Low (52W)
₹1,356.75 / ₹739.60
Beta
0.31

Valuation

Stock P/E
20.96
Industry PE
37.60
Forward P/E
-
PEG Ratio
-
Book Value
₹768.04
Price to Book
1.16
P/S
1.52
EV/EBITDA
30.45
Dividend Yield
1.12%

Profitability & Returns

ROCE
10.30%
ROE
-
ROA
-
Profit Margin
7.24%
Op Margin
2.35%
EPS (Latest Qtr)
₹7.45
EPS (TTM)
₹42.54

Balance Sheet & Liquidity

Debt/Equity
2.47
Quick Ratio
-
Current Ratio
-
Debt
₹26.83 Cr
Total Assets
₹1,281.19 Cr
Current Assets
₹1,103.89 Cr
Working Capital
₹892.97 Cr

Ownership

Promoter Holding
75.62%
Chg in Prom Hold
-
FII / Inst Holding
1.56%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
₹686.81 Cr
Total Revenue (TTM)
₹829.66 Cr
EBITDA
₹22.55 Cr
Free Cash Flow
-
Operating Cash Flow
-
Shares Outstanding
₹1.41 Cr
Gross Margin
51.00%
Payout Ratio
23.52%

Growth (CAGR)

Revenue 5Y
10.20%
Profit 5Y
25.22%
Revenue (YoY)
2.20%
Earnings (YoY)
-37.10%

PROS

  • Compounding revenue at 10.2% over 5 years.
  • Profit CAGR of 25.2% over 5 years.

CONS

  • Trading 34.3% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

Price Chart

NSE TradingView Screener.in

Fundamental Growth

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP ₹P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 TTKHLTCARE TTK Healthcare Limited NSEPHARMA 891.85 20.96 ₹1,260.21 Cr 1.12% 10.30% - 10.20% 25.22%
2 SUNPHARMA Sun Pharmaceutical Industries Limited NIFTY50NSEAIPHARMA 1,799.20 37.59 ₹4.32 L Cr 0.92% 17.94% 14.72% 10.39% 10.65%
3 DIVISLAB Divi's Laboratories Limited NSEPHARMA 6,667.00 68.97 ₹1.77 L Cr 0.45% 18.96% 16.19% 11.27% 12.08%
4 TORNTPHARM Torrent Pharmaceuticals Limited NSEPHARMA 4,410.80 68.96 ₹1.49 L Cr 0.86% 9.06% 16.98% 13.27% 20.21%
5 CIPLA Cipla Limited NIFTY50NSEAIPHARMA 1,401.00 29.16 ₹1.13 L Cr 0.93% 14.88% 11.74% 7.23% 11.45%
6 DRREDDY Dr. Reddy's Laboratories Limited NIFTY50NSEAIPHARMA 1,303.50 25.90 ₹1.09 L Cr 0.61% 14.00% 11.83% 10.96% -2.35%
7 ZYDUSLIFE Zydus Lifesciences Limited NSEPHARMA 1,077.70 21.51 ₹1.08 L Cr 0.09% 19.24% 18.32% 16.55% 36.99%
8 LUPIN Lupin Limited NIFTY_MIDNSEPHARMA 2,267.70 19.49 ₹1.04 L Cr 0.53% 28.42% 26.91% 19.10% 131.46%
9 MANKIND Mankind Pharma Limited NIFTY_MIDNSEPHARMA 2,375.60 51.29 ₹98,090.71 Cr 0.08% 13.78% 12.45% 17.73% 14.28%
Ad space

Quarterly Results

Figures in INR.

Metric Sep 2024Dec 2024Mar 2025Jun 2025Dec 2025
Revenue 198.49 Cr204.74 Cr186.49 Cr226.43 Cr209.30 Cr
Cost of Revenue 89.85 Cr98.03 Cr90.41 Cr101.82 Cr97.62 Cr
Gross Profit 108.64 Cr106.71 Cr96.09 Cr124.61 Cr111.68 Cr
Operating Expenses 102.42 Cr101.13 Cr85.81 Cr124.12 Cr106.77 Cr
Operating Income 6.22 Cr5.58 Cr10.27 Cr48.75 L4.92 Cr
EBITDA 25.93 Cr25.53 Cr23.45 Cr20.61 Cr16.99 Cr
Interest Expense 73.83 L82.33 L-47.07 L76.96 L68.32 L
Pretax Income 23.19 Cr22.59 Cr21.76 Cr17.65 Cr14.09 Cr
Tax Provision 5.99 Cr5.86 Cr5.61 Cr4.65 Cr3.55 Cr
Net Income 17.20 Cr16.73 Cr16.15 Cr13.00 Cr10.53 Cr
Diluted EPS 12.1711.84-9.207.45

Profit & Loss (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025
Revenue 596.07 Cr720.19 Cr747.64 Cr797.63 Cr
Cost of Revenue 287.02 Cr350.32 Cr340.54 Cr371.82 Cr
Gross Profit 309.06 Cr369.86 Cr407.10 Cr425.81 Cr
Operating Expenses 299.59 Cr350.77 Cr382.11 Cr398.88 Cr
Operating Income 9.47 Cr19.09 Cr24.99 Cr26.93 Cr
EBITDA 41.26 Cr79.79 Cr99.11 Cr118.61 Cr
Interest Expense 3.24 Cr5.24 Cr1.93 Cr1.95 Cr
Pretax Income 24.84 Cr61.64 Cr84.12 Cr108.33 Cr
Tax Provision 6.33 Cr16.97 Cr21.28 Cr26.67 Cr
Net Income 41.59 Cr639.71 Cr62.84 Cr81.66 Cr
Diluted EPS 29.43452.7244.4757.79

Compounded Sales Growth

5 Years:10.20%
1 Year:2.20%

Compounded Profit Growth

5 Years:25.22%
1 Year:-37.10%

Stock Price Performance

1 Year:-25.92%
6 Months:-20.94%
3 Months:-4.01%
1 Month:-0.68%

Balance Sheet (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets 558.55 Cr1,170.11 Cr1,206.30 Cr1,281.19 Cr
Current Assets 448.51 Cr1,066.07 Cr1,077.30 Cr1,103.89 Cr
Cash & Equivalents 14.86 Cr9.32 Cr10.96 Cr9.01 Cr
Inventory 78.92 Cr84.51 Cr96.99 Cr108.59 Cr
Receivables 53.58 Cr92.10 Cr86.44 Cr90.53 Cr
Total Liabilities 228.92 Cr216.73 Cr205.38 Cr216.14 Cr
Current Liabilities 220.53 Cr210.78 Cr201.52 Cr210.92 Cr
Long Term Debt ----
Total Debt 22.21 Cr27.33 Cr22.81 Cr24.22 Cr
Total Equity 329.63 Cr953.38 Cr1,000.92 Cr1,065.05 Cr
Shares Outstanding 1.41 Cr1.41 Cr1.41 Cr1.41 Cr

Cash Flows (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow 45.00 Cr-24.81 Cr-4.94 Cr-3.98 Cr
Investing Cash Flow -29.56 Cr31.69 Cr28.49 Cr20.10 Cr
Financing Cash Flow -10.13 Cr-12.43 Cr-21.91 Cr-18.08 Cr
Capital Expenditure -5.51 Cr-11.70 Cr-10.38 Cr-12.84 Cr
Free Cash Flow 39.49 Cr-36.51 Cr-15.33 Cr-16.82 Cr
Net Change in Cash 5.31 Cr-5.54 Cr1.64 Cr-1.95 Cr

Ratios (Annual)

Figures in %.

Metric Mar 2022Mar 2023Mar 2024Mar 2025
Gross Margin % 51.8%51.4%54.5%53.4%
Operating Margin % 1.6%2.7%3.3%3.4%
Net Margin % 7.0%88.8%8.4%10.2%
ROE % 12.6%67.1%6.3%7.7%
ROCE % 2.8%2.0%2.5%2.5%

Shareholding Pattern

Insiders
75.62%
Institutions
1.56%
Public Float
6.40%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for TTKHLTCARE

No recent headlines available.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All India Stocks